EUCTR2015-003331-36-AT进行中（未招募）1 期
A Phase IV, Open-label, Non-randomized, Clinical Trial to Evaluate the Safety of self-administered ADASUVE(R) (Staccato loxapine for inhalation) in Agitated Patients outside the hospital setting
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 500
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1. Male and female patients between the ages of 18-65 years, inclusive
- •2. Patients (or legal representative) willing and able to provide written Informed Consent Form.
- •3. Psychiatric patients already diagnosed of schizophrenia or bipolar disorder (according DSM-IV-TR, DSM-V or ICD-10 criteria).
- •4. Patients with an on-going agitation episode (mild or moderate), or
- •with a previous one within the 6 months prior to screening, attended and
- •managed in the hospital setting.
- •5. Previously treated with ADASUVE® with a positive outcome
- •(responders) according to (CGI-I) scale (defined as having a CGI-I score
- •of 1 or 2 at 2 hours after administration of the inhalation) or equivalent
- •clinical evaluation at the discretion of the investigator and they have not
- •developed bronchospasm after previous administration.
- •6. Patients free of active respiratory disease such as acute respiratory signs/symptoms (e.g., wheezing) or with active airways disease (asthma, chronic obstructive pulmonary disease [COPD] or emphysema).
- •7. Patient and/or caregiver/family able to:
- •a. understand and follow a specific training for the administration of
- •ADASUVE® outside the hospital setting,
- •b. identify/detect a respiratory problem
- •c. use of a bronchodilator if needed
- •8. Requirement of family or other caregiver support at study investigator criteria (defined as a patient’s relative or caregiver (male or female) = 80 year old, who spend = 3 consecutive hours with patient, with good physical and psychological health status and without physical limitations, reading and writing educational level and able to understand and follow the study procedures).
- •9. Availability of patient’s medical records data about the previous treatment with ADASUVE® at hospital setting.
- •10. If a female is of childbearing potential and sexually active (except if female is surgically sterile or post-menopausal with history of no menses for at least 24 months), patient must be non-lactating and non-pregnant (with a negative pregnancy test result at baseline visit) and have to agree to use a medically acceptable and effective birth control method throughout the study and for one week following the end of the study.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 500
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •1. Patient diagnosed with dementia.
- •2. Patients with serious and unstable illnesses including current hepatic, renal, gastroenterologic, respiratory, cardiovascular (including ischemic heart disease and congestive heart failure), endocrinologic, neurologic (including stroke, transient ischemic attack, subarachnoidal bleeding, brain tumor, encephalopathy, and meningitis).
- •3. Patients with a history of allergic reactions to loxapine or amoxapine
- •4. Patients who have received an investigational drug within 30 days prior to the current agitation episode must be excluded.
- •5. Patients who are considered by the investigator, for any reason, to be unable to self-administer the inhalation device.
研究者
相似试验
进行中（未招募）
1 期
A Clinical Trial to Evaluate the Safety of self-administered ADASUVE (Staccato loxapine for inhalation) in Agitated Patients outside the hospital setting.EUCTR2015-003331-36-NOFERRER INTERNACIONAL SA322
进行中（未招募）
1 期
An Open Label, Non-Randomised, Phase IV Clinical Trial to Determine the Transfer of Apixaban and Rivaroxaban in Breast Milk Following Oral AdministratioEUCTR2018-003852-19-GBKing's College London4
已完成
4 期
Clinical study to check the effectiveness and safety of AphtoFix® Mouth Ulcer Cream in subjects suffering from mouth ulcer.CTRI/2014/08/004918Bonyf AG
进行中（未招募）
1 期
DETOX StudyHIVMedDRA version: 20.0Level: LLTClassification code 10001509Term: AIDSSystem Organ Class: 100000004862EUCTR2018-001158-82-ESFundación SEIMC-GESIDA110
进行中（未招募）
1 期
This study compares clinically and microscopically the response to two treatments, a steroid in cream and a foam that contains a steroid and a vitamin D analogue in patients with plaque psoriasis.Plaque psoriasisEUCTR2017-004451-24-ESFundació Clínic per a la Reserca Biomèdica36